Sector News

Novozymes cuts jobs, says U.S. policy, Monsanto deal pose risks

January 19, 2017
Chemical Value Chain

Enzymes maker Novozymes will cut 198 jobs and invest more in emerging markets, it said on Wednesday, adding it could time take to recapture past growth rates amid uncertainty over U.S. renewable energy policy and the takeover of a key partner.

The Danish company’s business flourished after being spun off from drugmaker Novo Nordisk in 2000, but a lower oil price in recent years has hit demand for its enzymes used in detergents, animal feed and in the production of biofuel.

Its shares rose more than 5 percent in early trading after it posted slightly better than expected fourth-quarter earnings and announced a share buyback program worth up to 2 billion Danish crowns ($287 million).

But they had reversed to trade down 4.4 percent at 241.90 crowns by 1250 GMT.

“This is a new reality for Novozymes,” Chief Executive Peder Holk Nielsen told Reuters, referring to the job cuts and adding he “could no longer rely on growth to take us through the difficulties.”

Novozymes, which had 6,441 employees at the end of 2016, said it would increase investment in innovation and expand in South East Asia, Africa and the Middle East, but that would take time to boost revenues.

For 2017, the company expects organic sales growth – stripping out currency moves – of 2-5 percent. Last year, it cut its long-term organic sales growth expectations to 6-7 percent a year for 2017-2020, down from 8-10 percent before.

Nielsen did not set any longer-term targets on Wednesday, but said products launched in 2018-2020 would help return to historic growth rates.

He said Bayer’s takeover of key partner Monsanto could extend the market for Novozymes’ smart microbial crop-boosting products, known as inoculants, but acknowledged “transactional risks” from the deal.

“There’s a risk that the huge focus Monsanto has had on biological solutions will be less at Bayer,” he said. “That’s not our expectation, but we don’t know until the transaction is finalised.”

He also said the U.S. market for biofuels faced uncertainty, as incoming U.S. President Donald Trump could scale back a program designed cut greenhouse gas emissions that requires energy firms to blend ethanol and biodiesel into gasoline an diesel.

“My sense is that even if they remove the entire legislation on bioethanol, consumption in the United States will still be high, although probably a little less that today,” Nielsen said.

By Jacob Gronholt-Pedersen and Teis Jensen

Source: Reuters

comments closed

Related News

January 29, 2023

Dow and 3M cut thousands of jobs

Chemical Value Chain

3M and Dow have announced they are cutting thousands of roles from their global workforces in response to economic pressures. Dow has said it will cut 2,000 jobs across its global workforce (around 5%) in a bid to save US$1bn in 2023. The company says it will also cut costs by shutting down “select assets”, though it did not note where it would halt operations.

January 29, 2023

Sweden discovers Europe’s largest rare earths deposit

Chemical Value Chain

Sweden’s state mining firm has discovered what could be Europe’s largest rare earths deposit, and says it could help the bloc reduce its reliance on imports of minerals needed to manufacture clean technologies and meet climate targets.

January 29, 2023

Avantium to supply Henkel with plant-based FDCA

Chemical Value Chain

Henkel and Avantium have been partners since 2019, when Henkel joined the PEFerence consortium. This consortium of partners, coordinated by Avantium, aims to establish an innovative supply chain for FDCA and PEF (polyethylene furanoate).

How can we help you?

We're easy to reach